Skip to navigation Skip to main content

Oncology/Hematology CE Courses – Update

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured CE Courses

Optimizing Treatment Plans and Goals of Care for Metastatic Breast Cancer with CDK4/6 Inhibitors

Treatment Plans for MBC with CDK4/6 Inhibitors | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, ABIM MOC Points
1.00 CME CE: Increases clinicians’ knowledge and understanding of the clinical trial and real-world evidence for the CDK4/6i class. Exp 10/11/23
Managing Patients with CLL on BTK Inhibitor Therapy: BTK Inhibitor Treatment Selection in CLL

BTK Inhibitor Treatment Selection in CLL | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
0.25 CME CE: Small-molecule BTK inhibitors show excellent anti-tumor activity in the treatment of aggressive forms of CLL. This activity reviews selection of appropriate BTK inhibitors for patients with this type of leukemia. Exp 9/30/2023
Advances in Targeted Therapies for Non-Small Cell Lung Cancer: Optimizing Outcomes

Advances in Targeted Therapies for NSCLC | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
1.00 CME CE: Latest developments and critical insights in NSCLC management and the essential tools to evaluate efficacy, safety, clinical effectiveness. Exp 9/26/23
The Distinctive Role of BCMA-Targeting Therapies in Relapsed/Refractory Multiple Myeloma

BCMA-Targeting Drugs in R/R Multiple Myeloma | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
1.50 CME CE: Reviews data on how BCMA-targeting therapies help improve survival in patients with relapsed/refractory multiple myeloma. Exp 10/31/23
Hepatocellular Carcinoma: Individualizing Care and Optimizing Outcomes through Surveillance and Advances in Targeted Therapies and Immune Checkpoint Inhibitors

HCC: Advances in Targeted Therapies and ICIs | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
1.00 CME CE: Latest developments and insights in managing HCC and tools to evaluate efficacy, safety, clinical effectiveness and application. Exp 8/16/23
Getting Ahead of irAEs: Fostering Change in Structural Systems for Disadvantaged Populations

Getting Ahead of irAEs for Disadvantaged Populations | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), ABIM MOC Points, CE for Pharmacists, AAPA Category 1 CME Credit
0.75 CME CE: Webcast on how to use SDM to communicate treatment options, including ICIs, and build trust with patients to improve outcomes. Exp. 8/31/23

Click for Oncology More Courses

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next post in CE Courses